| 0.2 |
0.7 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.8 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.5 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.2 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.1 |
0.2 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.2 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.1 |
0.3 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) positive regulation of connective tissue replacement(GO:1905205) |
| 0.1 |
0.5 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.0 |
0.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.1 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.0 |
0.2 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.4 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.4 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.4 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.1 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.0 |
0.1 |
GO:1902624 |
regulation of granulocyte chemotaxis(GO:0071622) positive regulation of granulocyte chemotaxis(GO:0071624) regulation of neutrophil chemotaxis(GO:0090022) positive regulation of neutrophil chemotaxis(GO:0090023) regulation of neutrophil migration(GO:1902622) positive regulation of neutrophil migration(GO:1902624) |
| 0.0 |
0.1 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.2 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.0 |
0.1 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 |
0.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.0 |
0.1 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.0 |
0.4 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
0.0 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.0 |
0.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.3 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.0 |
0.1 |
GO:0098704 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 |
0.1 |
GO:1990641 |
cellular response to bile acid(GO:1903413) negative regulation of intestinal absorption(GO:1904479) response to iron ion starvation(GO:1990641) |
| 0.0 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.8 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.0 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.0 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.0 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
| 0.0 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:1902748 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 |
0.1 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.1 |
GO:1903936 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.0 |
0.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.0 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.0 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.0 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.0 |
0.3 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.0 |
0.0 |
GO:0042761 |
very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.0 |
0.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
